Compound asset sharing initiatives between pharmaceutical companies, funding bodies, and academia: Learnings and successes

Volume: 7, Issue: 4
Published: Jul 30, 2019
Abstract
Over recent years, there have been several initiatives to gain access to compounds which have been deprioritized by pharmaceutical companies, but which have a data package allowing them to be used in human experimental medicine studies. Such compounds provide an invaluable resource for probing human biology and disease pathology, for improving translational capabilities, and ultimately for repurposing to new therapeutic indications. The authors...
Paper Details
Title
Compound asset sharing initiatives between pharmaceutical companies, funding bodies, and academia: Learnings and successes
Published Date
Jul 30, 2019
Volume
7
Issue
4
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.